Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Holte

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Cytometry|January 1, 1991
Simultaneous assessment of chromatin structure, DNA content, and antigen expression by dual wavelength excitation flow cytometryT Stokke, H Holte, B Erikstein, et al.
Scandinavian Journal of Immunology|April 1, 1991
Differential effects of interferon-gamma and low molecular weight BCGF on growth of human B lymphocytes; interferon-gamma prolongs the increased c-MYC mRNA levels after activationJ Lømo, E B Smeland, T Stokke, et al.
Bone Marrow Transplantation|October 12, 1999
Persistent changes in the immune system 4-10 years after ABMTT Nordøy, A Kolstad, P Endresen, et al.
British Journal of Cancer|January 22, 2009
Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapyC E Kiserud, A Fosså, T Bjøro, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|October 23, 1997
Bone-marrow MR imaging before and after autologous marrow transplantation in lymphoma patients without known bone-marrow involvementH H Lien, V Blomlie, A K Blystad, et al.
International Journal of Cancer|January 15, 1989
Levels of myc protein, as analyzed by flow cytometry, correlate with cell growth potential in malignant B-cell lymphomasH Holte, T Stokke, E Smeland, et al.
British Journal of Haematology|May 19, 2004
Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapyA K Blystad, J Delabie, S Kvaløy, et al.
International Journal of Cancer|October 15, 1988
Triggering of neoplastic B cells via surface IgM and the cell surface antigens CD20 and CDw40. Responses differ from normal blood B cells and are restricted to certain morphologic subsetsK Beiske, E A Clark, H Holte, et al.
Medical and Pediatric Oncology|January 1, 1993
Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia")S H Slørdahl, E B Smeland, H Holte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
Clinical stage I and II Hodgkin's disease: long-term results of therapy without laparotomy. Experience at one institutionA F Abrahamsen, E Hannisdal, O Nome, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Cytometry|January 1, 1991
Simultaneous assessment of chromatin structure, DNA content, and antigen expression by dual wavelength excitation flow cytometryT Stokke, H Holte, B Erikstein, et al.
Scandinavian Journal of Immunology|April 1, 1991
Differential effects of interferon-gamma and low molecular weight BCGF on growth of human B lymphocytes; interferon-gamma prolongs the increased c-MYC mRNA levels after activationJ Lømo, E B Smeland, T Stokke, et al.
Bone Marrow Transplantation|October 12, 1999
Persistent changes in the immune system 4-10 years after ABMTT Nordøy, A Kolstad, P Endresen, et al.
British Journal of Cancer|January 22, 2009
Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapyC E Kiserud, A Fosså, T Bjøro, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|October 23, 1997
Bone-marrow MR imaging before and after autologous marrow transplantation in lymphoma patients without known bone-marrow involvementH H Lien, V Blomlie, A K Blystad, et al.
International Journal of Cancer|January 15, 1989
Levels of myc protein, as analyzed by flow cytometry, correlate with cell growth potential in malignant B-cell lymphomasH Holte, T Stokke, E Smeland, et al.
British Journal of Haematology|May 19, 2004
Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapyA K Blystad, J Delabie, S Kvaløy, et al.
International Journal of Cancer|October 15, 1988
Triggering of neoplastic B cells via surface IgM and the cell surface antigens CD20 and CDw40. Responses differ from normal blood B cells and are restricted to certain morphologic subsetsK Beiske, E A Clark, H Holte, et al.
Medical and Pediatric Oncology|January 1, 1993
Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia")S H Slørdahl, E B Smeland, H Holte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
Clinical stage I and II Hodgkin's disease: long-term results of therapy without laparotomy. Experience at one institutionA F Abrahamsen, E Hannisdal, O Nome, et al.
Pageof 10